Patients with cervical cancer who develop lung metastasis generally have a survival time of 3-5 years, and those who develop pleural effusion may have a shorter survival time of about 1-2 years, which needs to be further evaluated in the context of the patient’s condition and related treatment. If the patient is in good health, the survival time may be longer, but if the patient is in poor health and does not have standardized treatment, the survival time may be shorter. Cervical cancer is one of the three major gynecological malignant tumors that seriously threaten women’s health. The earlier cervical cancer is detected and treated, the better the prognosis. The earlier cervical cancer is detected and treated, the better the prognosis is. Patients with cervical cancer who have lung metastasis are considered to be in advanced stage, and their survival will be greatly affected at this time.